Innocoll Holdings PLC
(NASDAQ : INNL)

( )
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Pharmaceuticals Major

Company Profile

Innocoll Holdings Plc engages in the pharmaceutical business. It involves in the development and manufacturing of pharmaceutical products and medical devices. The company was utilizes proprietary collagen-based technology platform to develop biodegradable and bioresorbable products, and product candidates which can be broken down by the body without the need for surgical removal or applied topically. It distributes the following products: CollatampG globally outside of the United States, Septocoll within Europe and the Middle East, CollaGUARD within Europe, the Middle East and Asia and RegenePro in the United States. The company was founded in December 1997 and is headquartered in Athlone, RN.